Short: The Real Reason You're Not Losing Weight On A GLP-1

Your appetite disappears. You stop eating. The scale drops fast. And then it stops.

That sequence plays out for a lot of people on GLP-1 medications, and most of them assume the drug stopped working. The actual explanation is more mechanical than that, and understanding it changes what you need to do.

Start with the big picture. GLP-1 receptor agonists, which are drugs that mimic a hormone your gut naturally releases after eating, work primarily by slowing gastric emptying and signaling your brain that you are full. The appetite suppression can be dramatic, especially in the first few weeks. People who were eating 2,500 calories a day find themselves satisfied on 900. That gap is where the early weight loss comes from, and it comes quickly.

But here is what that early weight loss actually is.

Your body stores carbohydrates as something called glycogen, which is a form of glucose packed into your liver and muscle tissue for quick energy access. The thing about glycogen is that each gram of it holds somewhere between three and four grams of water alongside it. So when your food intake drops sharply and your body burns through those glycogen stores, it releases that water, and it all shows up on the scale at once. The first two to three weeks of significant scale movement is largely this. Not fat. Water and stored fuel leaving the body because the fuel tank went from full to empty.

This is not a bad thing. It is just not the same thing as fat loss, and conflating them is where the confusion starts.

Now the harder part.

When total food intake collapses the way it does on a GLP-1, protein intake almost always collapses with it. People are not strategically cutting calories. They are just not hungry, so they are not eating much of anything. And when protein is consistently low, your body runs a calculation that most people do not realize is happening.

Your body is always managing resources against survival needs. When protein coming in from food is insufficient to run the processes that keep you alive, your body turns to the next available source, which is the protein already stored in your muscle tissue. It breaks down muscle fibers to harvest amino acids, and those amino acids get redirected toward things like immune function, enzyme production, and keeping your organs running. The muscle was never the goal. It was just the supply chain.

This process is sometimes called lean mass catabolism, and it is not a flaw in the drug. It is your body doing exactly what bodies do when food becomes scarce. From a survival standpoint, carrying less muscle actually makes sense. Muscle is metabolically expensive tissue, meaning it burns calories just to exist, and if food is going to be limited, a smaller engine is more efficient.

The problem is that you are not trying to survive famine. You are trying to lose fat and keep the body composition that makes you functional, healthy, and capable of maintaining your results afterward.

Here is why this creates the plateau.

Every pound of muscle you lose reduces the number of calories your body burns at rest. This is sometimes called your resting metabolic rate, which is the baseline calorie burn that happens whether you move or not. As muscle tissue decreases, that baseline drops. So the same calorie deficit that was producing results in week three starts producing fewer results in week eight, not because the drug stopped working, but because the engine it is working against has gotten smaller. The deficit shrinks even if your eating habits stay the same.

This is the plateau. Not a mystery. Not a drug failure. A physics problem created by muscle loss.

The fix has two parts, and both of them are non-negotiable if you want to change this.

The first is treating protein like a medication with a dose. The target is your goal body weight in grams of protein per day, every day, whether you are hungry or not. If you want to weigh 170 pounds, you are eating 170 grams of protein. This is not a flexible guideline. On a GLP-1, your appetite cannot be your guide for protein because your appetite is pharmacologically suppressed. You have to override it intentionally.

The second is resistance training. Lifting weights two to three times per week sends a specific signal to your body that the muscle you are carrying is being used and therefore needs to be maintained. Without that signal, there is no reason for your body to hold onto tissue that costs calories to keep. The training and the protein work together. The training provides the stimulus. The protein provides the raw material.

A 2025 case series by Tinsley and Nadolsky looked at exactly this combination in patients using semaglutide or tirzepatide alongside structured training and intentional protein intake. The outcomes were different from what is typically reported with GLP-1 use alone. Patients lost an average of 33 percent of their body weight while losing only 6.9 percent of their lean mass. One patient gained 2.5 percent muscle mass while losing 26.8 percent of their total body weight. Same class of drugs. Completely different body composition outcomes. The variable was what they did with the appetite suppression the drug provided.

Case series data has limitations. It is a small number of patients without a control group, so it cannot prove causation on its own. But the mechanisms behind the outcome are well supported independently. Protein and resistance training preserve lean mass during caloric restriction. That is not new science. What is new is watching it applied specifically in the context of GLP-1 therapy.

The drug does one thing exceptionally well. It removes the hunger that makes eating less so difficult for most people. That is the window. But the window is not the result. What you do inside the window is what determines whether you lose fat and keep muscle, or lose both and rebuild the conditions for a plateau.

The people who treat the medication as the whole strategy tend to hit the wall. The people who treat it as the tool that makes the real strategy possible tend not to.

---

References

1. Tinsley GM, Nadolsky S. Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists: A case series. SAGE Open Medical Case Reports. 2025. Finding: Patients on semaglutide/tirzepatide who trained 3-5x/week and prioritized protein lost 33% body weight with only 6.9% muscle loss; one gained 2.5% muscle while losing 26.8% body weight. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness